Merck Covid drug linked to virus mutations that can spread between people, new study says

Indonesia Berita Berita

Merck Covid drug linked to virus mutations that can spread between people, new study says
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 NBCNewYork
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 63%

There is still no evidence that molnupiravir, sold under the brand name Lagevrio, has produced more transmissible or severe variants of Covid.

can cause mutations in the virus that occasionally spread to other people, raising questions about whether the drug has the potential to accelerate Covid's evolution.

The findings may increase scrutiny about the usefulness of the treatment, molnupiravir, which was one of the first Covid drugs available to doctors worldwide during the pandemic. Molnupiravir works by causing mutations in Covid's genetic information, which weakens or destroys the virus and reduces the amount of Covid in the body. However, the study published Monday in the scientific journal Nature found that Covid can sometimes survive treatment with molnupiravir, leading to mutated versions of the virus that have been found to spread to other patients.Researchers in the U.S. and U.K.

There is no evidence that molnupiravir, sold under the brand name Lagevrio, has produced more transmissible or severe variants of Covid, according to the study. But the findings are important for regulators who continue to assess the risks and benefits of molnupiravir, wrote Theo Sanderson, the lead author of the study and a researcher at the Francis Crick Institute in London, in a

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

NBCNewYork /  🏆 270. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

3M, Merck share losses lead Dow's nearly 100-point drop3M, Merck share losses lead Dow's nearly 100-point dropShares of 3M and Merck are trading lower Monday morning, sending the Dow Jones Industrial Average into negative territory. Shares of 3M and Merck are...
Baca lebih lajut »

Unintended Side Effect: Antiviral Drug Linked to Unusual COVID-19 Virus MutationsUnintended Side Effect: Antiviral Drug Linked to Unusual COVID-19 Virus MutationsA study found a connection between the antiviral drug molnupiravir and distinct SARS-CoV-2 mutations, emphasizing the need for careful assessment in drug development. Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the
Baca lebih lajut »

COVID drug molnupiravir may be driving the virus to mutate — should we worry?COVID drug molnupiravir may be driving the virus to mutate — should we worry?The antiviral molnupiravir may be shaping the evolution of the virus behind COVID-19, but we still don't know what this means for transmission or the emergence of variants.
Baca lebih lajut »

Biden got updated COVID-19 vaccine and the annual flu shot, the White House saysBiden got updated COVID-19 vaccine and the annual flu shot, the White House saysThe White House physician, Dr. Kevin O’Connor, says in a memo released by the White House on Saturday that the president got both shots on Friday and was vaccinated several weeks ago against the respiratory illness known as RSV.
Baca lebih lajut »

Top aide to Rep. Pat Ryan mismanaged COVID relief funds: auditTop aide to Rep. Pat Ryan mismanaged COVID relief funds: auditRep. Pat Ryan is facing questions after a top aide was was accused of mismanaging a coronavirus relief fund which resulted in about half the fund’s grants going to businesses that were inelig…
Baca lebih lajut »



Render Time: 2025-03-01 03:11:19